# Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

> **NCT04986657** · NA · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 325 (estimated)

## Conditions studied

- Whole Genome Sequencing
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes

## Interventions

- **DEVICE:** ChromoSeq

## Key facts

- **NCT ID:** NCT04986657
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-17
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 325 (ESTIMATED)
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04986657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04986657, "Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04986657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*